morgan and morgan semaglutide Best Practices in Texas Med Spas Dr. Benjamin Morgan, MD |

Semaglutide is approved as Ozempic (diabetes, December 2017), Wegovy (obesity, June 2021), and, in oral form, the Ozempic pill (diabetes, 2026, which reformulated and renamed Rybelsus) and the Wegovy pill (weight, December 2025)

Liraglutide Liraglutide is a daily injectable GLP-1 receptor agonist available in different doses for different indications

Your healthcare provider will calculate a specific starting dose of semaglutide based on your current progress and how your body has reacted to previous treatments

Based on the research, IFF has developed consumer personas to depict types of GLP-1 users and their changing preferences

Childhood obesity: public-health crisis, common sense cure

Use with caution if you have diabetes and kidney or liver issues